Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grassroots Biotechnology was an agricultural biotechnology company focused on the discovery and development of novel gene expression technologies and traits to improve crop yields and biofuel efficiency. The company specialized in identifying high-performance genetic promoters and regulatory elements that control when and where genes are active within a plant. By leveraging its proprietary bioinformatics and high-throughput screening platforms, Grassroots developed technologies to enhance carbon sequestration and optimize plant architecture. The company was ultimately acquired by Monsanto (now part of Bayer) to integrate its gene regulation expertise into their broader seeds and traits pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grassroots.